ZURICH (Reuters) – Roche said on Friday it launched a laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients.
The Elecsys SARS-CoV-2 antigen test is an automated laboratory assay intended as an aid in diagnosis of active SARS-CoV-2 infection, the Swiss drugmaker said in a statement.
(Reporting by Silke Koltrowitz; editing by Thomas Seythal)
